Group 1 - The ChiNext index fell by 2.0%, the ChiNext Mid 200 index decreased by 2.2%, and the ChiNext Growth index dropped by 2.4% [1] - China Securities believes that the A-share market is currently in a "market continuation" phase, with institutional benefits expected from mid-2026, alongside a recovery in price levels, domestic demand, and profit growth driven by industrial innovation [1] - The current A-share market is experiencing a spring market rally driven by a combination of liquidity and policy expectations, which is anticipated to be a significant investment window for the year [1] Group 2 - The E Fund ChiNext ETF tracks the ChiNext index, which consists of 100 stocks with large market capitalization and good liquidity, with a high proportion of emerging industries [3] - The index has seen a decline of 2.0% today, with a rolling price-to-earnings ratio of 43.4 times, compared to 42.5 times since its inception [3]

Group 1 - The core viewpoint of the article highlights a significant decline in AI industry stocks, with the China Securities Artificial Intelligence Theme Index dropping by 2.7% and the Shanghai Stock Exchange Sci-Tech Innovation Board AI Index falling by 3.1% [1] - Despite the market downturn, there is a notable capital inflow into AI-related investments, as evidenced by the net subscription of over 450 million units in the E Fund AI ETF (159819) throughout the day [1] - Huatai Securities emphasizes that the AI industry is in a rapid development phase, with continuous technological innovation and expansion of application scenarios, indicating a promising future for the sector [1] Group 2 - The article mentions that increased policy support and growing market demand will create new development opportunities for the AI industry chain [1] - It specifically points out that the mid-to-upstream sectors, such as chip technology and algorithm frameworks, will become key investment focuses in the future [1] - The long-term investment value of artificial intelligence is highlighted as significant, suggesting a positive outlook for investors in this sector [1]

Core Viewpoint - The Hong Kong stock market has been underperforming compared to the A-share market since Q4 2025, with liquidity issues and a lack of strong rebounds in key sectors like innovative drugs and technology being significant factors [1][2]. Group 1: Market Performance - The Hong Kong stock market has seen a correction trend since Q4 2025, with previously leading sectors like innovative drugs and technology struggling to rebound [1]. - By the end of last year, the Hang Seng Innovation Drug Index experienced a pullback, resulting in a lack of performance from related thematic funds, with only one fund, Huatai-PineBridge Hong Kong Advantage Selection, rising over 112% [2]. - The Hang Seng Technology Index also faced a high-level pullback, dropping approximately 15% in a single quarter, leading to an overall annual increase of only about 20% [2]. Group 2: Liquidity Issues - Liquidity has been identified as a core factor suppressing Hong Kong stock valuations, with many fundamentally strong stocks experiencing significant price drops due to low trading volumes [1][4]. - In 2025, the total fundraising amount from IPOs in Hong Kong reached approximately HKD 280 billion, with predictions of over HKD 300 billion in 2026, posing a challenge to market liquidity [4]. - The net inflow of southbound funds significantly slowed in December, with only HKD 23 billion entering the market, which is substantially lower than previous months [4]. Group 3: Investment Strategies - Fund managers emphasize the importance of prioritizing "win rate over odds" in Hong Kong stock investments, advocating for value investing and diversification to mitigate liquidity risks [7][8]. - Investors are advised to focus on the fundamentals and quality of companies, as historical integrity issues can significantly impact valuations [8]. - The current trend of RMB appreciation may provide a buffer against liquidity concerns, potentially attracting more capital into the Hong Kong market [6]. Group 4: Sector Focus - Fund managers are increasingly optimistic about the value proposition of Hong Kong stocks, particularly in technology and high-end manufacturing sectors, which are seen as having significant growth potential [9][10]. - There is a growing interest in consumer sectors, particularly in high-quality cultural products and competitive tea beverage companies, which are expected to achieve stable long-term growth [10].

1. Report Industry Investment Rating No relevant content provided. 2. Core View of the Report In Q4 2025, the new - issue market of public funds cooled down, but the issuance volume of FOF increased against the trend, and diversified allocation became the main development direction [1]. 3. Summary According to the Directory 3.1 Whole - Market Overview - **New - issue Quantity and Scale Declined Quarter - on - Quarter**: In Q4 2025, 406 new funds were established, with a total raised scale of about 285.434 billion yuan and an average raised scale of about 703 million yuan. Compared with Q3 2025, the number of new - issue funds decreased by 71, the new - issue scale decreased by about 93.427 billion yuan, and the average issuance scale dropped by 11.48% quarter - on - quarter. The new - issue scale of equity funds and fixed - income funds decreased, while that of FOF increased significantly [3][6]. - **Distribution of New - issue Fund Types**: The proportion of the new - issue scale of FOF increased significantly. In Q4 2025, the new - issue scale of equity funds accounted for 49.71%, and that of fixed - income funds accounted for 26.29%, while the new - issue scale of FOF/MOM accounted for 15.85%, a significant increase of about 14.13 percentage points compared with the previous quarter [14]. - **All New - issue Funds Were Successfully Raised, and Subscription Days Slightly Extended**: In Q4 2025, all new - issue funds were successfully raised, and the average subscription days were 16.7 days, slightly higher than that in Q3 2025 but still at a relatively low level in the past three years [28][31]. 3.2 Product Development Trend Analysis - **Equity Products**: - **Passive Equity Funds**: In Q4 2025, 183 index equity funds were established, with a total issuance scale of about 81.679 billion yuan. The number and scale of new - issue funds decreased significantly compared with Q3 2025, and the average issuance scale also decreased [35]. - **Active Equity Funds**: In Q4 2025, 106 active equity funds were established, with a total raised scale of about 60.218 billion yuan, accounting for 42.44% of equity funds. The number, scale, and scale proportion of new - issue funds continued to rise [42]. - **Fixed - Income Products**: In Q4 2025, 61 fixed - income funds were newly issued, with a total raised scale of about 75.035 billion yuan, a decrease of 25 in number and about 66.989 billion yuan in scale compared with Q3 2025, a quarter - on - quarter decline of 47.17% [46]. - **FOF**: In Q4 2025, 42 FOF were established, with a total raised scale of about 45.246 billion yuan, a significant increase of about 38.714 billion yuan quarter - on - quarter. The average raised scale was about 1.077 billion yuan, a quarter - on - quarter increase of 693 million yuan. FOF products are evolving towards diversified allocation [52][53]. - **QDII Products**: In Q4 2025, 6 new QDII funds were established. Two Brazilian ETFs, Huaxia Bradesco Brazil Ibovespa ETF and E Fund Itau Brazil IBOVESPA ETF, were over - subscribed during the issuance process, indicating that the Brazilian market is attracting investors' attention [59]. - **Mutual Recognition Products**: In Q4 2025, 1 mutual recognition fund, BOC Hong Kong Global Equity Fund, was newly established, with an issuance scale of about 1.524 billion yuan, which is a stock - type fund [61].

Core Viewpoint - The Hong Kong pharmaceutical sector is experiencing active performance, with significant gains in key stocks and positive forecasts for companies like WuXi AppTec, indicating a strong recovery in the CRO and CDMO demand side, alongside a potential "Davis Double Play" for the sector [1] Group 1: Market Performance - As of 15:00 on January 13, the Hang Seng Biotechnology Index and the CSI Hong Kong Stock Connect Pharmaceutical and Health Comprehensive Index both rose by 1.0% [1] - Notable stock performances include WuXi AppTec rising over 7%, WuXi Biologics increasing over 5%, and Weigao Group and WuXi AppTec's subsidiary rising over 3% [1] Group 2: Company Forecasts - WuXi AppTec announced a profit forecast for the fiscal year 2025, expecting a net profit attributable to shareholders of 19.151 billion yuan, representing a year-on-year growth of approximately 102.65% [1] - Institutions predict that WuXi AppTec's order growth will continue to outpace global peers in 2026, indicating strong market positioning [1] Group 3: Industry Insights - According to Zhongtai Securities, multiple factors are driving a gradual recovery in the demand side for CRO and CDMO within the pharmaceutical sector, combined with a supply-side clearance over the past three years [1] - The Hang Seng Biotechnology Index focuses on leading biotechnology firms within the Hong Kong Stock Connect, covering various sub-sectors including biotechnology, pharmaceuticals, and medical devices [1] - The CSI Hong Kong Stock Connect Pharmaceutical and Health Comprehensive Index targets leading companies in the pharmaceutical and health industry, encompassing medical devices and innovative drugs [1] Group 4: Investment Tools - The E Fund Hang Seng Biotechnology ETF (159105) and the E Fund Hong Kong Stock Connect Pharmaceutical ETF (513200) track the aforementioned indices, providing diversified investment tools for investors to capitalize on opportunities in the pharmaceutical industry [2]

1月13日午后，半导体板块震荡调整。截至14点，中证半导体材料设备主题指数下跌2%，相关ETF获资 金加码，半导体设备ETF易方达（159558）盘中净申购达3800万份。 消息面上，上周三星与SK海力士宣布将一季度服务器、PC及手机用存储芯片报价较去年四季度上调 60%～70%，主要原因在于AI驱动需求爆发，供需缺口持续扩大。 有分析称，存储大周期上行，国产半导体材料及设备板块有望受益。在AI算力需求的持续赋能下，存 储行业开启量价齐升的上行周期，存储原属于传统周期品，但在AI时代下成长属性有所强化，存储芯 片产线的扩建将有望进一步打开存储相关设备需求远期空间，长期来看有望拉动设备厂商业绩释放。 中证半导体材料设备主题指数由40只业务涉及半导体材料和半导体设备的股票组成，根据申万三级行业 分类，指数半导体设备占比为63%，半导体材料占比24%，在国产化趋势中具备较强弹性。投资者可通 过半导体设备ETF易方达（159558）等产品把握产业景气度上行投资机会。 （文章来源：每日经济新闻） ...

Core Viewpoint - The semiconductor equipment and chip sectors are experiencing adjustments, leading to a decline in various STAR Market indices, with the STAR 100 Index down by 1.3%, the STAR Composite Index down by 1.6%, the STAR 50 Index down by 1.8%, and the STAR Growth Index down by 3.0% as of midday trading [1]. Group 1: STAR Market Indices Performance - The STAR 50 Index, which tracks the top 50 stocks on the STAR Market, has a market capitalization and liquidity focus, with over 65% of its composition in semiconductors and nearly 80% combined with medical devices, software development, and photovoltaic equipment [3]. - The STAR 100 Index, which includes 100 medium-cap stocks, focuses on small and medium-sized innovative enterprises, with over 75% of its composition in electronics, power equipment, and biopharmaceuticals [4]. - The STAR Composite Index encompasses all securities in the STAR Market, covering 17 primary industries, and has a decline of 1.6% as of midday trading [6]. Group 2: ETF Performance - The E Fund STAR 50 ETF (588080) has a current scale of 77 billion yuan, with a tracking error of only 0.26% for 2025 and an excess return of 0.66%, ranking first among comparable products [1]. - The E Fund STAR Growth ETF tracks the STAR Growth Index, which consists of 50 stocks with high growth rates in revenue and net profit, with over 65% of its composition in the electronics and communications sectors, and has seen a decline of 3.0% [7].

Core Viewpoint - The market showed mixed performance in the morning session, with the "Dividend+" index rising against the trend, indicating a potential shift towards value and cash flow-focused investments [1]. Group 1: Market Performance - The Guozheng Free Cash Flow Index increased by 1.1%, the Guozheng Value 100 Index rose by 0.5%, and the CSI Dividend Index gained 0.3% by midday [1]. - Related ETFs, including the E Fund Value ETF (159263) and E Fund Free Cash Flow ETF (159222), attracted significant capital inflows, totaling 47 million yuan and 74 million yuan respectively over the last three trading days [1]. Group 2: Index Characteristics - The Guozheng Value 100 Index employs a three-dimensional screening system based on "high dividends + high free cash flow + low price-to-earnings ratio" to select value stocks, demonstrating stable historical performance [1]. - The Guozheng Free Cash Flow Index consists of 100 stocks with high free cash flow levels, primarily from the industrial, materials, and consumer discretionary sectors, which together account for over 70% of the index [4]. - The E Fund Value ETF (159263) and E Fund Free Cash Flow ETF (159222) track the aforementioned indices, providing investors with opportunities to capitalize on these investment styles [1].

Group 1 - The core viewpoint of the article indicates that the A-share market is expected to perform well due to the resonance of two factors: the restructuring of the international order and China's industrial innovation by 2026 [1] - The market is anticipated to show a pattern of rising initially and then stabilizing, supported by active capital and elevated valuations [1] - The A500 ETF from E Fund (159361) recorded a half-day trading volume of nearly 5 billion yuan [1] Group 2 - The CSI A500 index decreased by 0.03%, while the CSI A100 index increased by 0.01%, and the CSI A50 index rose by 0.4% at the midday close [1] - There is an emphasis on monitoring increased volatility and the rhythm that aligns with the fundamentals in the market [1]

Group 1 - The artificial intelligence sector opened high but retreated, with the CSI Artificial Intelligence Theme Index down by 1.5% and the Shanghai Stock Exchange Sci-Tech Innovation Board AI Index down by 1.2% [1] - Despite the market downturn, there was a significant inflow of funds into the AI sector, with the E Fund AI ETF (159819) seeing a net subscription of over 350 million units in half a day [1] - CICC forecasts a potential profit growth of approximately 4.7% for the entire A-share market by 2026, highlighting an increase in high-growth industries and sectors nearing performance improvement inflection points [1] Group 2 - The report emphasizes the rising market weight of new economy sectors and suggests focusing on the impact of AI innovation trends, increased inflection points, and elastic opportunities from a capacity cycle perspective [1] - Structural highlights include the trend of industries expanding overseas, indicating potential growth areas within the AI sector [1]